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Abstract
Transient cardiomyopathy is an uncommon occurrence in patients with
anaphylaxis. Catecholamine induced direct toxicity is one of the
proposed mechanisms. We report a case of cardiomyopathy in a child
with anaphylaxis who was treated with multiple doses of epinephrine as
well as a continuous infusion of epinephrine. A twenty one month old girl
with egg allergy presented to our hospital with anaphylaxis, after
multiple doses of epinephrine injections, developed cardiorespiratory
dysfunction and required endotracheal intubation and mechanical
ventilation. Work up showed depressed cardiac function, which
improved with milrinone and furosemide infusions. Conclusion:
Epinephrine is the treatment of choice for anaphylaxis however caution
should be exercised when administering multiple doses of epinephrine.
Myocardial function needs to be assessed in children with persistent
hypotension after anaphylaxis and catecholamine-induced
cardiomyopathy should be considered in children with anaphylaxis when
severe myocardial dysfunction is present.
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Introduction
Transient cardiomyopathy is an uncommon occurrence in patients with
anaphylaxis and catecholamine induced direct toxicity is one of the
proposed mechanisms. Epinephrine is the treatment of choice for
anaphylaxis. Catecholamine-induced cardiomyopathy should be
considered in children with persistent hypotension following multiple
doses of epinephrine and needs myocardial function assessment.
Case presentation
A twenty-one-month old female presented to our hospital emergency
room with an acute onset of a perioral rash, vomiting, cough, and
generalized itching. She had a past medical history of egg allergy; one
hour prior to admission she had eaten meat loaf, which had been
prepared with milk and eggs. Her parents administered an oral
antihistamine and brought her to the emergency room because of
continued respiratory distress.
In the emergency room, during a period of twenty minutes, the patient
received three injections of epinephrine at a dose of 0.01mg/kg (one dose
intramuscular (IM) and two doses intravenous (IV)) and a racemic
epinephrine nebulization. Despite these treatments, her work of
breathing continued to increase and she became hypotensive. Three
boluses of 20 ml/kg of normal saline were infused and a continuous
infusion of epinephrine was initiated at a dose of 1 mcg/kg/min for
treatment of the hypotension.
Upon admission to the Pediatric Intensive Care Unit (PICU), the child
was noted to have increased work of breathing, tachycardia (180-200
bpm) and poor peripheral perfusion. The patient was intubated and
mechanically ventilated. The patient developed pink frothy secretions at
the time of intubation. Her chest X-ray was interpreted as consistent
with pulmonary edema. Sinus tachycardia and nonspecific ST segment
and T wave changes were noted on the electrocardiogram and an
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echocardiogram revealed depressed left ventricular systolic function with
an ejection fraction of 44%. Initial cardiac enzyme levels were elevated:
troponin (3.2 ng./ml, upper normal level 0.08ng./ml), Creatine
phosphokinase (CPK-MB) (11.5 ng./ml, upper normal level 3.5 ng./ml)
and beta type natriuretic peptide (BNP- B)(5,000 pg. /ml, upper normal
level 99 pg. /ml). Continuous infusions of milrinone at 0.25mcg/kg/min
and furosemide at 0.02mg/kg/hr were started and the epinephrine
infusion was weaned off. Over the next ten days, serial echocardiograms
showed improvement in cardiac function with a final ejection fraction of
69% and normalization of cardiac enzymes. The child was discharged
home fourteen days after admission. Serial laboratory and ejection
fraction values are presented in table 1.
Discussion
Anaphylaxis is an acute life-threatening event which may manifest with
severe systemic symptoms. Patients with the most severe symptoms
develop these symptoms more rapidly. (1) In patients with anaphylaxis
onset outside of the hospital setting, food is the most common etiology;
food induced anaphylaxis is the cause of 30% of all fatal anaphylactic
reactions. (1) Peanuts, tree nuts, and biphasic reactions are more
commonly associated with fatal outcomes and require more than one
dose of epinephrine. (2)
Patients with severe anaphylaxis may also present with cardiac
complications. (3) As mast cells are abundant in the heart, activated
cardiac mast cells may act both as source and target for chemical
mediators during anaphylaxis. (3) Thus, our patient’s hemodynamic
status worsened after escalation of epinephrine therapy and her cardiac
enzyme levels increased suggesting possible myocardial injury. Because
the child improved after epinephrine was discontinued, we suspect the
patient may have developed a catecholamine-induced cardiomyopathy.
Epinephrine is the cornerstone of anaphylaxis treatment. (1) It has a
narrow therapeutic index and produces transient adverse effects; rarely it
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can cause serious side effects. (1) High dose of epinephrine
administration can cause myocardial stunning and severe global
myocardial hypokinesis. (4) Very high plasma catecholamine levels and
sustained sympathetic stimulation have been associated with progression
of heart failure and a decreased left ventricular ejection fraction. (4)
Diffuse myocardial destruction with myocyte loss, necrosis, and
extensive fibrosis were observed in experimental studies following
administration of high doses of epinephrine. (5) Such pathological
changes have also been noted in patients with catecholamine excess
states, such as those with pheochromocytoma, who developed
catecholamine-induced cardiomyopathy. (6)
Studies have shown that in patients with stress induced cardiomyopathy
(also known as Tako-tsubo cardiomyopathy) and with catecholamine
excess states, endomyocardial biopsies demonstrate a unique form of
myocyte injury with contraction band necrosis. (7) Myocardial stunning
from neurogenic causes has a similar mechanism, resulting from
enhanced sympathoneural activity causing elevated catecholamines and
neuropeptides levels. (8) One of the proposed mechanisms of myocardial
dysfunction after high dose epinephrine therapy is the unfavorable effect
of high dose epinephrine on the balance between myocardial oxygen
supply and demand. (9) Furthermore, there is experimental evidence
that high dose epinephrine may have a negative inotropic influence
through activation of GI pathways. (10)
Patients with catecholamine induced cardiomyopathy can present with
congestive heart failure and pulmonary edema. (6) Treatment includes
diuretics, ACE inhibitors, and inotropic support. Milrinone is indicated
in progressive heart failure as it decreases systemic vascular resistance,
improves lusitropy and increases cardiac output; furthermore, milrinone,
does not increase myocardial oxygen consumption. (11) In refractory
cases,Extra Corporeal Membrane Oxygenation (ECMO) is a valuable
treatment option. (12) Once the epinephrine levels return to normal,
cardiomyopathy changes reverse within days to weeks of the acute insult.
(13)
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Conclusion
In summary, our patient with allergy to eggs developed severe
anaphylaxis after exposure to eggs. Subsequently, she developed
myocardial dysfunction and injury associated with epinephrine
administration. She improved after discontinuation of epinephrine and
with supportive therapy. However, we cannot rule out direct cardiac
effects of the anaphylactic response itself. (4) Vasodilatory shock is still
the most common type of shock in children with anaphylaxis, however
catecholamine-induced cardiomyopathy should be considered in
children with anaphylaxis when myocardial dysfunction is present.
Myocardial function needs to be assessed in children with persistent
hypotension after anaphylaxis. Caution should be exercised when
administering multiple doses of epinephrine for management of
anaphylaxis.
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Table 1. Showing serial myocardial injury markers and ejection fraction
on echocardiogram.
Day of
Admission 1 2 3 5 7 10
BNP (pg/ml) 5000 4940 2720 1391 607 454
Troponin (ng/ml) 3.2 2.8 1.28 0.34 0.15 0.01
CPKMB (ng/ml) 11.5 29.9 43 32.8 12.9 5
Ejection Fraction
(%) 44 48 — 55 62 69
BNP, beta type natriuretic peptide; CPK MB, Creatine phosphokinase.
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